Early mechanisms of glucose improvement following laparoscopic ileal interposition associated with a sleeve gastrectomy evaluated by the euglycemic hyperinsulinemic clamp in type 2 diabetic patients with bmi below 35

Digestive Surgery

Volumn 28, Issue 4, 2011, Pages 293-298

  Vencio, Sergio ^a   Stival, Alessandro ^b   Halpern, Alfredo ^c   Depaula, Carolina C L ^a   Depaula, Aureo L ^b  

^a PONTIFÍCIA UNIVERSIDADE CATÓLICA DE GOIÁS   (Brazil)

^b HOSPITAL DE ESPECIALIDADES   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cell function; Euglycemic hyperinsulinemic clamp; Ileal interposition; Insulin sensitivity; Metabolic surgery; Sleeve gastrectomy; Surgical treatment of diabetes; Type 2 diabetes

Indexed keywords

C PEPTIDE; INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BARIATRIC SURGERY; BLOOD; BODY MASS; FEMALE; GASTRECTOMY; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMAN; ILEUM; INSULIN RESISTANCE; LAPAROSCOPY; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; WEIGHT REDUCTION;

ADULT; AREA UNDER CURVE; BARIATRIC SURGERY; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; ILEUM; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 80052340103     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000330272     Document Type: Article

References (33)

1. DeFronzo RA, Ferannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and ASCVD. Diabetes Care 1991; 14: 173-194.
2. Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 1769-1778. (Pubitemid 40923091)
3. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34): UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 854-865.
4. Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA: The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 1992; 41: 1575-1586.
5. Kahn S: The Importance of r-cell failure in the development and progression of type 2 diabetes. J Clin Endoc Metab 2001; 86: 4047-4058. (Pubitemid 32848511)
6. Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC: UKPDS 26: sulfonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabetes Med 1998; 15: 297-303. (Pubitemid 28168509)
7. Kahn SE, Zraika S, Utzschneider KM, Hull RL: The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 2009; 52: 1003-1012.
8. Del Prato S, Ferrannini E, DeFronzo RA: Evaluation of insulin sensitivity in man; in Clarke WL, Larner J, Pohl SL (eds): Methods in Diabetes Research. Clinical Methods. New York John Wiley & Sons, 1986, vol 2, pp 35-76.
9. Tripathy D, Wessman Y, Glullstrom M, Tuomi T, Groop L: Importance of obtaining independent measures of insulin secretion and insulin sensitivity during the same test. Diabetes Care 2003; 26: 1395-1401. (Pubitemid 36929169)
10. Sjöström L, Lindroos AK, Peltonen M, Torgereson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström C, Sullivan M, Wedel H, Swedish Obese Subjects Study Scientific Group: Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693. (Pubitemid 39665322)
11. Rubino F, Schauer PR, Kaplan LM, Cummings DE: Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Ann Rev Med 2010; 61: 393-411.
12. DePaula AL, Macedo ALV, Rassi N, Machado CA, Schraibman V, Silva LQ, Halpern H: Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc 2008; 22: 706-716. (Pubitemid 351341683)
13. DePaula AL, Halpern A, Muscelli E, Mari A, Stival A, Vencio V, Ferrannini E: Improvement in insulin sensitivity and B-cell function following ileal interposition with sleeve gastrectomy in type 2 diabetic patients: potential mechanisms. J Gastrointest Surg 2011;15:1344-1353.
14. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26:S5-S20.
15. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-E223. (Pubitemid 9249478)
16. DePaula AL, Macedo AL, Rassi N, Vencio S, Machado CA, Mota BR, Silva LQ, Halpern A, Schraibman V: Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus. Surg Endosc 2008; 22: 2670-2678.
17. Duska F, Andel M, Kubena A, Macdonald IA: Effects of acute starvation on insulin resistance in obese patients with and without type 2 diabetes mellitus. Clin Nutr 2005; 24: 1056-1064. (Pubitemid 41782464)
18. Ferrannini E, Mingrone G: Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care 2009; 32: 514-520.
19. Ferrannini E, Mari A: Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 2004; 47: 943-956. (Pubitemid 38757009)
20. Bruce DG, Chisholm DJ, Storlien LH, Kraegen EW: Physiological importance of deficiency in early prandial insulin secretion in non-insulin dependent diabetes. Diabetes 1988; 37: 736-744. (Pubitemid 19043181)
21. Dixon JB, O'Brien PE: Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002; 25: 358-363. (Pubitemid 41079636)
22. Camastra S, Manco M, Mari A, Greco AV, Frascerra S, Mingrone G, Ferrannini E:p-cell function in severely obese type 2 diabetic patients. Long-term effects of bariatric surgery. Diabetes Care 2007; 30: 1002-1004. (Pubitemid 46556603)
23. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK: Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 2003; 52: 1098-1103. (Pubitemid 36523342)
24. Morinigo R, Lacy AM, Casamitjana R, Delgado S, Gomis R, Vidal J: GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg 2006; 16: 1594-1601. (Pubitemid 46032812)
25. Briatore L, Salani B, Andraghetti G, Danovaro C, Sferrazzo E, Scopinaro N, Adami GF, Maggi D, Cordera R: Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion. Obesity 2008; 16: 77-81. (Pubitemid 351271953)
26. Rudovich NN, Rochlitz HJ, Pfeiffer AF: Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients. Diabetes 2004; 53: 2359-2365. (Pubitemid 39145590)
27. Kautzky-Willer A, Thomaseth K, Clodi M, Ludvik B, Waldhausl W, Prager R, Pacini G: Beta-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects. Metabolism 1996; 45: 486-491. (Pubitemid 26115676)
28. DePaula AL, Macedo AL, Schraibman V, Mota BR, Vencio S: Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34. Surg Endosc 2009; 23: 1724-1732.
29. DePaula AL, Macedo ALV, Mota BR, Schraibman V: Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surg Endosc 2009; 23: 1313-1320.
30. DePaula A, Stival A, Halpern A, Vencio S: Thirty-day morbidity and mortality of the laparoscopic ileal interposition associated with sleeve gastrectomy for the treatment of type 2 diabetic patients with BMI ! 35: an analysis of 454 consecutive patients. World J Surg 2011; 35: 102-108.
31. DePaula AL, Stival AR, Macedo A, Ribamar J, Mancini M, Halpern A, Vencio S: Prospective randomized controlled trial comparing 2. versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21-34 kg/m 2 . Surg Obes Relat Dis 2010; 6: 296-305.
32. Hari Kumar KVS, Ugale S, Gupta N, Naik V, Kumar P, Bhaskar P, Modi KD: Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther 2009; 11: 785-789.
33. Goel R, Amin P, Goel M, Marik S: Early remission of type 2 diabetes mellitus by laparoscopic ileal transposition with sleeve gastrectomy surgery in 23-35 BMI patients. Int J Diabetes Dev Ctries 2010;2:91-96.